Literature DB >> 7036382

Treatment of syphilis: a short critical review.

E Panconesi, G Zuccati, A Cantini.   

Abstract

Four decades of treatment of syphilis with penicillin confirm the absolute superiority of this drug in all stages of the disease. Various long-acting repository preparations (particularly benzathine penicillin G) are used in treatment of early and late syphilis, and even for prophylactic treatment, with satisfactory results. Treatment schedules and follow-up criteria for examination and indications for retreatment vary little among various authors and countries. Adverse reactions to penicillin, in particular the allergic reactions, make alternative treatment with other antibiotics (tetracyclines, erythromycin, etc) sometimes necessary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7036382

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

1.  In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.

Authors:  Klaus-Peter Hunfeld; Eva Ruzic-Sabljic; Douglas E Norris; Peter Kraiczy; Franc Strle
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.

Authors:  R K Straubinger; B A Summers; Y F Chang; M J Appel
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 3.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Modern neurosyphilis--a critical analysis.

Authors:  K G Jordan
Journal:  West J Med       Date:  1988-07

Review 5.  Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.

Authors:  Klaus-Peter Hunfeld; Volker Brade
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

6.  In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum.

Authors:  L V Stamm; J T Stapleton; P J Bassford
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.